- Accuray hires Asia Pacific GM
Accuray Inc. (NSDQ:ARAY) announced that Bob Wong has returned to Accuray as general manager of the APAC (Asia Pacific, including Australia but excluding India and Japan) region effective Oct. 14, 2010.
Read more - Fluidnet Corp. appoints Benjamin Bulkley president and CEO
Fluidnet Corp. announced that its board of directors unanimously appointed Benjamin Bulkley as president and CEO, effective immediately. He succeeds the company’s founder, Jeffrey Carlisle, who will serve as Fluidnet’s chief innovation officer.
Read more - Minnesota software firm Healthland names new CEO
Healthland, a healthcare software firm that focuses on rural hospitals, appointed Angie Franks as president and CEO.
Read more - AngioDynamics announces election of Kevin Gould to board of directors
AngioDynamics (NSDQ:ANGO) announced that Kevin Gould, 56, was elected to its board of directors at the company’s annual shareholders meeting Oct. 18. Gould is the former COO of Tyco Healthcare; his election fills the vacancy created by the retirement of Paul Echenberg from the company’s board.
Read more - Aethlon Medical announces the appointment of Miriam Provost as its U.S. regulatory advisor
Aethlon Medical, Inc. (OTC:AEMD) announced that it has retained Miriam Provost, Ph.D., of the Biologics Consulting Group Inc., to be the company’s U.S. regulatory advisor.
Read more - Ximedica continues to expand executive management team
Ximedica has again expanded its executive management team to keep pace with growth in the company’s medical device development and regulatory business. The company recently announced the hiring of Thomas Varricchione as principal advisor, clinical and regulatory affairs; Andre LaFreniere as vice president, business development; and David Fink, vice president, product development.
Read more - Former chief scientific officer of Warner-Lambert and president of Parke-Davis Pharmaceutical Research joins Aastrom board of directors
Aastrom Biosciences Inc. (NSDQ:ASTM) announced that Ronald Cresswell, Ph.D., Hon. D.Sc., FRSE, has joined the company’s board of directors. Cresswell is the former senior vice president and chief scientific officer of Warner-Lambert and has served on the board of directors of Esperion Therapeutics Inc., Allergan Inc., Curagen Corp. and Vasogen Inc.
Read more - Patient Safety Technologies appoints new CFO
Patient Safety Technologies Inc. (OTC:PSTX) announced the appointment of David Dreyer as vice president and COO.
Read more - Regenicin Appoints Renowned New York Dermatologist, Dr. Gervaise Gerstner to Scientific Advisory Board
Regenicin Inc. (OTC:WDST) announced the appointment of Dr. Gervaise Gerstner to its scientific advisory board. Dr. Gerstner is a board-certified dermatologist and assistant clinical professor of dermatology at Mount Sinai Hospital in New York.
Read more - Response Genetics Inc. announces departure of COO
Response Genetics Inc. (NSDQ:RGDX) announced the departure of Michael McNulty as the company’s COO. During this transition period, Christine Meda, a consultant for the company, formerly from Roche Diagnostics, will continue to coordinate business development and commercialization efforts.
Read more - Signal Genetics announces establishment of scientific advisory board
Signal Genetics, the parent company of Myeloma Health, announced the formation of its scientific advisory board: Dr. Kenneth Anderson, director, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute; Keith Stewart, professor of medicine, Mayo Clinic; David Gelfand, chief scientific officer at WaferGen Biosystems Inc.; Cynthia French, chief scientific officer at Exiqon Inc.; Dr. Craig Keyes, formerly an executive with United Health Group.
Read more
